The Significance of Integrin Inhibitors in Modern Medicine
The intricate mechanisms of cellular communication and interaction are central to understanding and treating a myriad of diseases. Integrins, a class of cell surface receptors, are pivotal players in these processes, mediating cell adhesion, migration, and signaling. Consequently, targeting integrins with specific inhibitors has become a significant strategy in modern medicine, particularly in oncology and regenerative medicine. NINGBO INNO PHARMCHEM CO.,LTD., as a specialized manufacturer of advanced pharmaceutical materials, plays a crucial role in supplying the research community with key compounds like Cyclo(L-arginylglycyl-L-a-aspartyl-D-phenylalanyl-N-methyl-L-valyl) (CAS 188968-51-6).
Cyclo(L-arginylglycyl-L-a-aspartyl-D-phenylalanyl-N-methyl-L-valyl), commonly known as Cilengitide, is a synthetic cyclic pentapeptide that acts as a potent inhibitor of integrins, specifically targeting the αvβ3 and αvβ5 subtypes. These integrins are frequently upregulated in various cancers, contributing to tumor angiogenesis, invasion, and metastasis. By blocking the function of these integrins, Cilengitide can effectively inhibit these critical cancer progression pathways.
The therapeutic potential of integrin inhibitors like Cilengitide makes them highly sought-after for research and development. As a leading supplier of this high-purity white powder, NINGBO INNO PHARMCHEM CO.,LTD. supports scientists working on developing new anti-cancer drugs and diagnostic tools. The precision required in formulating these agents means that the quality of the intermediate, such as our CAS 188968-51-6, is non-negotiable. We ensure our manufacturing processes yield a product that meets the exact specifications needed for advanced biomedical research.
For institutions and companies looking to buy Cyclo(L-arginylglycyl-L-a-aspartyl-D-phenylalanyl-N-methyl-L-valyl), understanding its mechanism of action is as important as ensuring its quality. Whether for preclinical studies exploring anti-angiogenic properties or for the synthesis of novel drug conjugates, our product provides a reliable foundation. We encourage researchers to inquire about our CAS 188968-51-6 price and availability, as we are committed to supporting the scientific community with our specialized peptide offerings. Partner with NINGBO INNO PHARMCHEM CO.,LTD. for your critical pharmaceutical intermediate needs.
Perspectives & Insights
Alpha Spark Labs
“supports scientists working on developing new anti-cancer drugs and diagnostic tools.”
Future Pioneer 88
“The precision required in formulating these agents means that the quality of the intermediate, such as our CAS 188968-51-6, is non-negotiable.”
Core Explorer Pro
“We ensure our manufacturing processes yield a product that meets the exact specifications needed for advanced biomedical research.”